MarketPulse

market capitalization loss

18 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

ImmunityBio Plummets 21% After FDA Warning Letter Over Misleading Cancer Drug Claims

ImmunityBio faces securities lawsuit after FDA warning letter over misleading Anktiva efficacy claims. Stock plunged 21%, erasing $2 billion in market value.
IBRXsecurities class actionstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

ImmunityBio Plummets 21% After FDA Flags Cancer Drug Misleading Claims

ImmunityBio shares plunge 21% after FDA flags misleading cancer drug claims; $2B market cap erased. Securities lawsuit filed.
IBRXstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Apollo Global Faces Major Securities Lawsuit Over Epstein Relationship Concealment

Apollo Global Management faces securities lawsuit alleging false statements about Jeffrey Epstein relationship. Stock fell 15%, erasing $12 billion in market value. Lead Plaintiff deadline: May 1, 2026.
APOAPOSAPOpAsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

ImmunityBio Plummets 21% After FDA Flags Cancer Drug Misleading Claims

ImmunityBio faces securities lawsuit after FDA warning over misleading Anktiva cancer claims. Stock drops 21%, erasing $2B market cap.
IBRXsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

ODDITY Tech Stock Crashes 49% as Ad Partner Algorithm Shift Triggers Revenue Collapse

ODDITY Tech ($ODD) crashed 49% after disclosing 30% Q1 revenue decline from advertising partner algorithm changes. Securities lawsuit filed alleging misstatements about platform strength.
ODDsecurities class actionmisleading statements
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Apollo faces securities lawsuit over Epstein ties; stock down 15% after revelations

Apollo Global Management faces class action lawsuit over undisclosed Epstein connections. Stock plummeted 15%, erasing $12B in market value following February investigative reports.
APOAPOSAPOpAstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Driven Brands Stock Crashes 33% on Accounting Restatement Shock

Driven Brands ($DRVN) plummets 33% after announcing material financial misstatements requiring restatement. Securities class action expanded; $900M market cap erased.
DRVNshareholder lawsuitsecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Portnoy Law Firm

Newegg Stock Plunges 17.7% as Chairman Detained; Law Firm Launches Fraud Probe

Law firm investigates Newegg after 17.7% stock decline following disclosure that chairman He Zhitao was detained for personal legal issues.
NEGGsecurities fraudinvestor losses
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Securities Fraud Cases Mount: Ostin, NuScale Face Class Action Lawsuits Over Investor Losses

Law firms pursue class action lawsuits against Ostin Technology and NuScale Power over alleged securities fraud. Ostin investors lost 94% in single day; NuScale accused of misrepresenting partner credentials.
SMROSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

IBRX Stock Crashes 21% After FDA Warning on Unsupported Cancer Claims

ImmunityBio faces securities lawsuit after FDA warns of misleading Anktiva efficacy claims. Stock plunges 21%, erasing $2B in market value.
IBRXstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

ImmunityBio Stock Crashes 21% as FDA Warning Triggers $2B Market Wipeout

ImmunityBio ($IBRX) shares plunged 21% after FDA warning over false Anktiva efficacy claims, erasing $2 billion in market value and triggering securities litigation.
IBRXsecurities class actionstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

ImmunityBio Plunges 21% After FDA Warning Over Unsupported Cancer Claims

ImmunityBio shares plunge 21% after FDA warning over unsupported cancer treatment claims, erasing $2 billion in market value and triggering securities litigation.
IBRXsecurities class actionstock price decline
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Apollo Global Hit With Securities Class Action Over Undisclosed Epstein Ties

Apollo Global Management faces securities lawsuit over undisclosed Jeffrey Epstein ties revealed in investigative reports. Stock plummeted 15%, erasing $12B in market cap.
APOAPOSAPOpAstock declinesecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Energy Storage Stock EOSE Crashes 39% on Revenue Miss, Manufacturing Woes Spark Lawsuit

EOSE shares plunged 39% after missing FY 2025 revenue targets by 25% and revealing manufacturing delays. Securities lawsuit alleges management concealed production issues from investors.
EOSErevenue misssecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Nuclear Power and Tech Stocks Hit by Major Securities Fraud Cases as Deadline Looms

Major securities fraud cases filed against NuScale Power and Ostin Technology Group involve $110M scheme and partner misrepresentation. Lead plaintiff deadlines approaching April 2026.
SMROSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

EOSE Stock Crashes 39% as Eos Energy Faces Lawsuit Over Hidden Manufacturing Woes

$EOSE plummeted 39% after revealing 25% FY2025 revenue shortfall and production problems. Securities lawsuit alleges management concealed scaling issues from investors.
EOSErevenue misssecurities class action
GlobeNewswire Inc.GlobeNewswire Inc.··Bragar Eagel & Squire, P.C.

Major Class Actions Target Nuclear Innovator NuScale and Tech Firm Ostin Over Fraud Allegations

Class action lawsuits filed against $SMR developer NuScale and $OSTN over securities fraud, including $110M scheme and misrepresented nuclear partnerships.
SMROSTsecurities fraudclass action lawsuit
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Kyndryl Targeted in Securities Suit Following 55% Stock Decline and Control Deficiencies

Kyndryl faces securities lawsuit after 55% stock plunge following disclosure of internal control weaknesses, delayed filings, executive departures, and SEC inquiry.
KDsecurities class actioninternal control weaknesses